Egypt's stocks start week in red as benchmark EGX 30 slides 1.51%    Egypt's stocks end week in red as benchmark EGX 30 falls 0.4%    EGYPS 2022 taking place at a vital time ahead of COP27    Egypt works on charting cooperation strategies with international institutions for 5 years: Al-Mashat    Maha karara joins AAIB as Head of Corporate Communications, Sustainability    Over 2.4 million newborns examined for hearing impairment: Health Ministry    Netflix releases trailer of Arab adaption of 'Perfect Strangers' film    Balqees to headline concert celebrating launch of streaming giant LIVENow in MENA    Sawsan Badr to be honoured at Aswan Women Film Festival    Al-Sisi follows up on 'Great Transfiguration Project' in St. Catherine    Cairo, London stress need to strengthen cooperation to face climate change    Foreigners account for 22.6% of Egypt's T-bills issuances in 1H 2021: CBE    MP Abdel Hady Al-Qasby calls government to facilitate and support NGOs    Egypt's ambassador to Italy passes away    Egypt confirms readiness to help African countries face terrorism and extremism    An estimated 235 million people needed humanitarian assistance and protection in 2021, an increase of 40% compared to 2020: IOM Egypt    Egypt, DRC discuss water cooperation during WYF    Egypt, DR Congo discuss boosting bilateral cooperation during WYF    Cameroonian police probe assault on three Algerian journalists covering AFCON    Pharaohs start AFCON 2021 campaign with fierce clash against Nigeria    Foreign Ministry opens capacity building course for French-speaking African diplomats    BRICS development bank admits Egypt as new member    Nermien Ismail Schools opens a new campus in O'West    Netherlands Embassy, E7kky Magazine celebrate success of 21 Egyptian women    Women make up 45% of Egyptian Atomic Energy Authority staff    Yas Island hosts travel partners at Formula 1 Etihad Airways Abu Dhabi Grand Prix 2021    Olaf Scholz becomes Germany's new leader, ending Merkel 16-year historic era    Egypt's trade with Nile basin countries climbs 26% y-o-y in 9 months    The unvaccinated prohibited from entry to Egypt state institutions starting December 1    Egypt's iron and steel exports jump 197% in 8 months    Ethiopia halts work at its embassy in Egypt for 'economic reasons'    It's a bit frustrating to draw at home: Real Madrid keeper after Villarreal game    Russia says it's in sync with US, China, Pakistan on Taliban    Shoukry reviews with Guterres Egypt's efforts to achieve SDGs, promote human rights    Sudan says countries must cooperate on vaccines    Johnson & Johnson: Second shot boosts antibodies and protection against COVID-19    Egypt to tax bloggers, YouTubers    Egypt's FM asserts importance of stability in Libya, holding elections as scheduled    Brazil calls up 8 EPL players for World Cup qualifying    We mustn't lose touch: Muller after Bayern win in Bundesliga    Egypt records 36 new deaths from Covid-19, highest since mid June    Egypt sells $3 bln US-dollar dominated eurobonds    Sisi calls on House, Senate to commence second legislative sessions on 3, 5 October    Gamal Hanafy's ceramic exhibition at Gezira Arts Centre is a must go    Italian Institute Director Davide Scalmani presents activities of the Cairo Institute for ITALIANA.IT platform    Qa'a play showing at Lycee El Horreya Theatre, Alexandria is a must go    On International Museum Day, Egypt opens two new museums at Cairo Airport    Old Cairo's Al-Fustat will be revamped on Egyptian President's directives    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



FACTBOX: Countries resume use of AstraZeneca vaccine, while some lose confidence
Published in Ahram Online on 25 - 03 - 2021

Many countries are resuming use of the Anglo-Swedish drugmaker's vaccine after the European Medicines Agency (EMA) and the World Health Organization (WHO) said the benefits outweighed the risks following investigations into reports of blood clots.
Fresh data on Thursday showed the AstraZeneca vaccine was 76% effective in preventing symptomatic coronavirus infections in a new analysis of its US trial.
A Ukrainian servicewoman who died two days after taking the Covishield - the vaccine made by AstraZeneca partner Serum Institute of India - had not complained of any ill effects after taking the shot, the health ministry said on Wednesday. A poll on Sunday showed European trust in the vaccine had plunged.
At least 17 countries had suspended or delayed use after reports of hospitalisations with clotting issues and bleeding, while Asia is accelerating inoculations.
UN agency WHO, which has urged inoculations continue, said on Friday that more than 20 million doses of the vaccine had been given to Europeans, with over 27 million doses of Covishield administered in India.
** Below is a list of countries and regions to resume or start using the vaccine after the investigations, in alphabetical order:
Australia:
The pharmaceutical regulator approved on Sunday the local manufacturing of the vaccine by CSL.
Bulgaria:
Resumed inoculations from March 19.
Cyprus:
Cyprus, which suspended the vaccine on March 15, restarted administering it on March 19.
Canada:
Said the vaccine was safe but added a warning to the vaccine's label about rare blood clots.
France:
Medical regulator approved the resumed use of AstraZeneca's vaccine on March 19, but said it should only be given to people aged 55 and older.
Finland:
To resume using the AstraZeneca vaccine from Monday, but will only give it to people aged 65 and over.
Germany:
Resumed administering the AstraZeneca vaccine from March 19.
Indonesia:
Began using the vaccine on Monday after suspending it last week. But the Food and Drug agency has warned against its use on people with blood clotting disorders.
Ireland:
Plans to resume rollout of the vaccine in the coming days for all those aged 18 and over, a committee said on March 19, after suspending it on March 14.
Italy:
Resumed using the vaccine on March 19, and Italians who decline to be inoculated with it will be given an alternative later on.
Latvia:
Also said it would restart administering the shots.
Lithuania:
Restarted administering the vaccine on March 19.
The Netherlands:
The health minister said on March 18 that the country would resume using the vaccine this week.
South Korea:
President Moon Jae-in, 68, plans to get the shot on Tuesday after the government said it could be used on older people.
Spain:
Resumed administering AstraZeneca's coronavirus vaccine from Wednesday, with little sign public enthusiasm has been dented.
Sweden:
Will resume use of the vaccine for people aged 65 and older, its health agency said on Thursday, but keep the pause in place for younger Swedes.
Taiwan:
Premier Su Tseng-chang got the vaccine on Monday as the island began its immunisation campaign.
Thailand:
Began use on March 15, with Prime Minister Prayuth Chan-ocha becoming the first to be inoculated, after Thailand delayed rollout the week before.
Uzbekistan:
Will launch its vaccination campaign with the AstraZeneca vaccine from April 1.
** Below is a list of countries and regions where suspensions continue for now, in alphabetical order:
Austria:
Suspended use of one batch of the vaccine on March 7 after the death of one person and the illness of another.
Cameroon:
Suspended administration of the vaccine it was scheduled to receive on March 20 as part of the global vaccines sharing scheme COVAX, the health ministry said.
Denmark:
Will prolong its suspension of the shot by three weeks pending further investigations after its two-week pause ended on March 25. A local survey indicated that one in three Danes would decline to get the shot.
Georgia:
Has limited the use of the vaccine after a nurse died of anaphylactic shock, news agency TASS reported on March 19.
Iceland:
Suspended vaccine use on March 11.
Norway:
Health authorities said on March 17 it was too soon to say if the vaccine causes blood clots after halting rollout on March 11.
Romania:
Temporarily stopped vaccinating people with one batch of vaccine on March 11.


Clic here to read the story from its source.